GlaxoSmithKline PLC Director/PDMR Shareholding (7095N)
August 10 2017 - 11:43AM
UK Regulatory
TIDMGSK
RNS Number : 7095N
GlaxoSmithKline PLC
10 August 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Ms E Walmsley
=== ======================== ===========================================
b) Position/status Chief Executive Officer
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mr R G Connor
=== ======================== ===========================================
b) Position/status President, Global Manufacturing & Supply
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mr S Dingemans
=== ======================== ===========================================
b) Position/status Chief Financial Officer
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mr N Hirons
=== ======================== ===========================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mr D S Redfern
=== ======================== ===========================================
b) Position/status Chief Strategy Officer
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Ms C Thomas
=== ======================== ===========================================
b) Position/status SVP, Human Resources
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mr P C Thomson
=== ======================== ===========================================
b) Position/status President, Global Affairs
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Dr P J T Vallance
=== ======================== ===========================================
b) Position/status President, R&D
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mrs V A Whyte
=== ======================== ===========================================
b) Position/status Company Secretary
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------- -----------------------
GBP15.1861 8 (partnership shares)
----------- -----------------------
GBP15.1861 8 (matching shares)
----------- -----------------------
=== ======================== ===========================================
d) Aggregated information
Aggregated volume
Price
16 Ordinary Shares
GBP15.1861
=== ======================== ===========================================
e) Date of the transaction 2017-08-09
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEBLFFDVFZBBF
(END) Dow Jones Newswires
August 10, 2017 11:43 ET (15:43 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
